Gualano, G., CAPONE, S., MATTEELLI, A., & Palmieri, F. (2016). New Antituberculosis Drugs: From Clinical Trial to Programmatic Use. Infectious Disease Reports, 8(2), 6569. https://doi.org/10.4081/idr.2016.6569
Chicago Style (17th ed.) CitationGualano, Gina, Susanna CAPONE, Alberto MATTEELLI, and Fabrizio Palmieri. "New Antituberculosis Drugs: From Clinical Trial to Programmatic Use." Infectious Disease Reports 8, no. 2 (2016): 6569. https://doi.org/10.4081/idr.2016.6569.
MLA (9th ed.) CitationGualano, Gina, et al. "New Antituberculosis Drugs: From Clinical Trial to Programmatic Use." Infectious Disease Reports, vol. 8, no. 2, 2016, p. 6569, https://doi.org/10.4081/idr.2016.6569.
Warning: These citations may not always be 100% accurate.